🇺🇸 FDA
Pipeline program

-, Pred Forte 10 mg/ml colirio en suspensión

IMGN853-0425

Phase 2 small_molecule active

Quick answer

-, Pred Forte 10 mg/ml colirio en suspensión for platinum-resistant advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers. is a Phase 2 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).

Program details

Company
AbbVie Deutschland GmbH & Co. KG
Indication
platinum-resistant advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers.
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials